| Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis Nature 476 (7359), 214-219, 2011 | 3024 | 2011 |
| Ocrelizumab versus placebo in primary progressive multiple sclerosis X Montalban, SL Hauser, L Kappos, DL Arnold, A Bar-Or, G Comi, ... New england journal of medicine 376 (3), 209-220, 2017 | 1983 | 2017 |
| Ocrelizumab versus interferon beta-1a in relapsing multiple sclerosis SL Hauser, A Bar-Or, G Comi, G Giovannoni, HP Hartung, B Hemmer, ... New England Journal of Medicine 376 (3), 221-234, 2017 | 1907 | 2017 |
| Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis International IBD Genetics Consortium (IIBDGC), C Agliardi, L Alfredsson, ... Nature genetics 45 (11), 1353-1360, 2013 | 1359 | 2013 |
| An automated tool for detection of FLAIR-hyperintense white-matter lesions in multiple sclerosis P Schmidt, C Gaser, M Arsic, D Buck, A Förschler, A Berthele, M Hoshi, ... Neuroimage 59 (4), 3774-3783, 2012 | 1259 | 2012 |
| ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis X Montalban, R Gold, AJ Thompson, S Otero-Romero, MP Amato, ... Multiple Sclerosis Journal 24 (2), 96-120, 2018 | 963 | 2018 |
| Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility International Multiple Sclerosis Genetics Consortium*†, ANZgene, ... Science 365 (6460), eaav7188, 2019 | 961 | 2019 |
| New concepts in the immunopathogenesis of multiple sclerosis B Hemmer, JJ Archelos, HP Hartung Nature Reviews Neuroscience 3 (4), 291-301, 2002 | 856 | 2002 |
| Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients S Jarius, K Ruprecht, B Wildemann, T Kuempfel, M Ringelstein, C Geis, ... Journal of neuroinflammation 9, 1-17, 2012 | 846 | 2012 |
| A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking CE Teunissen, A Petzold, JL Bennett, FS Berven, L Brundin, M Comabella, ... Neurology 73 (22), 1914-1922, 2009 | 764 | 2009 |
| Role of the innate and adaptive immune responses in the course of multiple sclerosis B Hemmer, M Kerschensteiner, T Korn The Lancet Neurology 14 (4), 406-419, 2015 | 684 | 2015 |
| Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment M Krumbholz, D Theil, S Cepok, B Hemmer, P Kivisäkk, RM Ransohoff, ... Brain 129 (1), 200-211, 2006 | 644 | 2006 |
| Intrathecal pathogenic anti–aquaporin‐4 antibodies in early neuromyelitis optica JL Bennett, C Lam, SR Kalluri, P Saikali, K Bautista, C Dupree, ... Annals of Neurology: Official Journal of the American Neurological …, 2009 | 617 | 2009 |
| EFNS guidelines on diagnosis and management of neuromyelitis optica J Sellner, M Boggild, M Clanet, RQ Hintzen, Z Illes, X Montalban, ... European journal of neurology 17 (8), 1019-1032, 2010 | 612 | 2010 |
| TCR ligand discrimination is enforced by competing ERK positive and SHP-1 negative feedback pathways I Štefanová, B Hemmer, M Vergelli, R Martin, WE Biddison, RN Germain Nature immunology 4 (3), 248-254, 2003 | 571 | 2003 |
| Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis A Petzold, LJ Balcer, PA Calabresi, F Costello, TC Frohman, EM Frohman, ... The Lancet Neurology 16 (10), 797-812, 2017 | 527 | 2017 |
| Immune surveillance in multiple sclerosis patients treated with natalizumab O Stüve, CM Marra, KR Jerome, L Cook, PD Cravens, S Cepok, ... Annals of Neurology: Official Journal of the American Neurological …, 2006 | 501 | 2006 |
| Acute disseminated encephalomyelitis: an update T Menge, B Hemmer, S Nessler, H Wiendl, O Neuhaus, HP Hartung, ... Archives of neurology 62 (11), 1673-1680, 2005 | 500 | 2005 |
| Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis S Cepok, D Zhou, R Srivastava, S Nessler, S Stei, K Büssow, N Sommer, ... The Journal of clinical investigation 115 (5), 1352-1360, 2005 | 448 | 2005 |
| Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis S Cepok, B Rosche, V Grummel, F Vogel, D Zhou, J Sayn, N Sommer, ... Brain 128 (7), 1667-1676, 2005 | 431 | 2005 |
